Glucose impairs B-1 cell function in diabetes (Q61937349)

1

0 references

S Ståhlman

2

0 references

L Grahnemo

3

0 references

L Fogelstrand

Clinical and Experimental Immunology

5

0 references

language of work or name

English

0 references

publication date

October 2013

0 references

published in

0 references

volume

174

0 references

issue

1

0 references

page(s)

129-38

0 references

cites work

High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells

1 reference

12 December 2020

Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies

1 reference

12 December 2020

B-1 cells in the bone marrow are a significant source of natural IgM.

1 reference

12 December 2020

Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion

1 reference

12 December 2020

Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity

1 reference

12 December 2020

Type 2 diabetes as an inflammatory disease

1 reference

12 December 2020

Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity

1 reference

12 December 2020

Origins and functions of B-1 cells with notes on the role of CD5

1 reference

12 December 2020

Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice

1 reference

12 December 2020

Hyperglycemia induces apoptosis of human pancreatic islet endothelial cells: effects of pravastatin on the Akt survival pathway

1 reference

12 December 2020

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

1 reference

12 December 2020

Hyperglycemia and the pathobiology of diabetic complications

1 reference

12 December 2020

Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection

1 reference

12 December 2020

Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction

1 reference

12 December 2020

The importance of natural IgM: scavenger, protector and regulator

1 reference

12 December 2020

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

1 reference

12 December 2020

High Glucose-Induced Expression of Proinflammatory Cytokine and Chemokine Genes in Monocytic Cells

1 reference

12 December 2020

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea

1 reference

12 December 2020

Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose

1 reference

12 December 2020

Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease

1 reference

12 December 2020

CD5+ peritoneal B cells express high levels of membrane, but not secretory, C mu mRNA

1 reference

12 December 2020

Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women

1 reference

12 December 2020

Hyperglycemia and glycation in diabetic complications.

1 reference

12 December 2020

Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myo

1 reference

12 December 2020

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

1 reference

12 December 2020

Low proliferation capacity of lymphocytes from alloxan-diabetic rats: involvement of high glucose and tyrosine phosphorylation of Shc and IRS-1.

1 reference

12 December 2020

New perspectives in B-1 B cell development and function

1 reference

12 December 2020

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

12 December 2020

Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens

1 reference

12 December 2020

Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden

1 reference

12 December 2020

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice

1 reference

12 December 2020

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

1 reference

12 December 2020

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins

1 reference

12 December 2020

Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury

1 reference

12 December 2020

Role of natural and immune IgM antibodies in immune responses

1 reference

12 December 2020

Common infections in diabetes: pathogenesis, management and relationship to glycaemic control.

1 reference

12 December 2020

The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice

1 reference

12 December 2020

B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions

1 reference

12 December 2020